메뉴 건너뛰기




Volumn 44, Issue 4, 1999, Pages 477-481

Protective effect of trovafloxacin, ciprofloxacin and ampicillin against Streptococcus pneumoniae in a murine sepsis model

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CIPROFLOXACIN; PENICILLIN G; TROVAFLOXACIN;

EID: 0032858562     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/44.4.477     Document Type: Article
Times cited : (6)

References (20)
  • 3
    • 0030459726 scopus 로고    scopus 로고
    • Acute community-acquired sinusitis
    • Gwaltney, J. M. (1996). Acute community-acquired sinusitis. Clinical Infectious Diseases 23, 1209-23.
    • (1996) Clinical Infectious Diseases , vol.23 , pp. 1209-1223
    • Gwaltney, J.M.1
  • 5
    • 0030003732 scopus 로고    scopus 로고
    • Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the united states during the winter months of 1994-1995: Results of a 30-center national surveillance study
    • Doern, G. V., Brueggemann, A., Holley, H. P. & Rauch, A. (1996). Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994-1995: results of a 30-center national surveillance study. Antimicrobial Agents and Chemotherapy 40, 1208-13.
    • (1996) Antimicrobial Agents and Chemotherapy , vol.40 , pp. 1208-1213
    • Doern, G.V.1    Brueggemann, A.2    Holley, H.P.3    Rauch, A.4
  • 6
    • 0030179960 scopus 로고    scopus 로고
    • Antimicrobial resistance among lower respiratory tract isolates of Streptococcus pneumoniae: Results of a 1992-93 Western Europe and USA collaborative surveillance study
    • The Alexander Project Collaborative Group
    • Goldstein, F. W. & Acar, J. F. (1996). Antimicrobial resistance among lower respiratory tract isolates of Streptococcus pneumoniae: results of a 1992-93 Western Europe and USA collaborative surveillance study. The Alexander Project Collaborative Group. Journal of Antimicrobial Chemotherapy 38, Suppl. A, 71-84.
    • (1996) Journal of Antimicrobial Chemotherapy , vol.38 , Issue.SUPPL. A , pp. 71-84
    • Goldstein, F.W.1    Acar, J.F.2
  • 7
    • 0028237653 scopus 로고
    • Drug-resistant pneumococcal infections in the United States. A problem for clinicians, laboratories, and public health
    • Simberkoff, M. S. (1994). Drug-resistant pneumococcal infections in the United States. A problem for clinicians, laboratories, and public health. Journal of the American Medical Association 271, 1875-6.
    • (1994) Journal of the American Medical Association , vol.271 , pp. 1875-1876
    • Simberkoff, M.S.1
  • 8
    • 0031431208 scopus 로고    scopus 로고
    • Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996-1997 respiratory season
    • The Laboratory Investigator Group
    • Thornsberry, C., Ogilvie, P., Kahn, J. & Mauriz, Y. (1997). Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996-1997 respiratory season. The Laboratory Investigator Group. Diagnostic Microbiology and Infectious Diseases 29, 249-57.
    • (1997) Diagnostic Microbiology and Infectious Diseases , vol.29 , pp. 249-257
    • Thornsberry, C.1    Ogilvie, P.2    Kahn, J.3    Mauriz, Y.4
  • 10
    • 0030757351 scopus 로고    scopus 로고
    • The chemistry and biological profile of trovafloxacin
    • Brighty, K. E. & Gootz, T. D. (1997). The chemistry and biological profile of trovafloxacin. Journal of Antimicrobial Chemotherapy 39, Suppl. B, 1-14.
    • (1997) Journal of Antimicrobial Chemotherapy , vol.39 , Issue.SUPPL. B , pp. 1-14
    • Brighty, K.E.1    Gootz, T.D.2
  • 11
    • 0029834825 scopus 로고    scopus 로고
    • Activity of the new fluoroquinolone trovafloxacin (CP-99,219) against DNA gyrase and topoisomerase IV mutants of Streptococcus pneumoniae selected in vitro
    • Gootz, T. D., Zaniewski, R., Haskell, S., Schmieder, B., Tankovic, J., Girard, D. et al. (1996). Activity of the new fluoroquinolone trovafloxacin (CP-99,219) against DNA gyrase and topoisomerase IV mutants of Streptococcus pneumoniae selected in vitro. Antimicrobial Agents and Chemotherapy 40, 2691-7.
    • (1996) Antimicrobial Agents and Chemotherapy , vol.40 , pp. 2691-2697
    • Gootz, T.D.1    Zaniewski, R.2    Haskell, S.3    Schmieder, B.4    Tankovic, J.5    Girard, D.6
  • 12
    • 0029401201 scopus 로고
    • In-vitro activity of the fluoroquinolone trovafloxacin against penicillin-susceptible and -resistant Streptococcus pneumoniae
    • Klugman, K. & Wasas, A. (1995). In-vitro activity of the fluoroquinolone trovafloxacin against penicillin-susceptible and -resistant Streptococcus pneumoniae. Journal of Antimicrobial Chemotherapy 36, 873-4.
    • (1995) Journal of Antimicrobial Chemotherapy , vol.36 , pp. 873-874
    • Klugman, K.1    Wasas, A.2
  • 14
    • 0025862429 scopus 로고
    • Correlation between in vitro and in vivo activity of antimicrobial agents against Gram-negative bacilli in a murine infection model
    • Fantin, B., Leggett, J., Ebert, S. & Craig, W. A. (1991). Correlation between in vitro and in vivo activity of antimicrobial agents against Gram-negative bacilli in a murine infection model. Antimicrobial Agents and Chemotherapy 35, 1413-22.
    • (1991) Antimicrobial Agents and Chemotherapy , vol.35 , pp. 1413-1422
    • Fantin, B.1    Leggett, J.2    Ebert, S.3    Craig, W.A.4
  • 17
    • 0029047653 scopus 로고
    • Evaluation of CP-99,219, a new fluoroquinolone, for treatment of experimental penicillin-and cephalosporin-resistant pneumococcal meningitis
    • Paris, M. M., Hickey, S. M., Trujillo, M., Shelton, S. & McCracken, G. H. (1995). Evaluation of CP-99,219, a new fluoroquinolone, for treatment of experimental penicillin-and cephalosporin-resistant pneumococcal meningitis. Antimicrobial Agents and Chemotherapy 39, 1243-6.
    • (1995) Antimicrobial Agents and Chemotherapy , vol.39 , pp. 1243-1246
    • Paris, M.M.1    Hickey, S.M.2    Trujillo, M.3    Shelton, S.4    McCracken, G.H.5
  • 18
    • 0029122988 scopus 로고
    • In vivo efficacy of trovafloxacin (CP-99,219), a new quinolone with extended activities against gram-positive pathogens, Streptococcus pneumoniae, and Bacteroides fragilis
    • Girard, A. E., Girard, D., Gootz, T. D., Faiella, J. A. & Cimochowski, C. R. (1995). In vivo efficacy of trovafloxacin (CP-99,219), a new quinolone with extended activities against gram-positive pathogens, Streptococcus pneumoniae, and Bacteroides fragilis. Antimicrobial Agents and Chemotherapy 39, 2210-16.
    • (1995) Antimicrobial Agents and Chemotherapy , vol.39 , pp. 2210-2216
    • Girard, A.E.1    Girard, D.2    Gootz, T.D.3    Faiella, J.A.4    Cimochowski, C.R.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.